Global Pneumococcal Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 05-Apr-2019
No. of pages: 117
Inquire Before Buying

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.

The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

The global Pneumococcal Vaccine market is valued at 7140 million US$ in 2018 and will reach 1263900 million US$ by the end of 2025, growing at a CAGR of 91.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Pneumococcal Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccine in these regions.

This research report categorizes the global Pneumococcal Vaccine market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Pfizer

- GSK

- MSD

- Sanofipasteur

- CDIBP

Market size by Product

- PPSV 23

- PCV 7/13

- PCV 10

Market size by End User

- Child

- Adult

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Pneumococcal Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Pneumococcal Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Pneumococcal Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pneumococcal Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Pneumococcal Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Pneumococcal Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccine Market Size Growth Rate by Product
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by End User
1.5.1 Global Pneumococcal Vaccine Market Size Growth Rate by End User
1.5.2 Child
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Vaccine Market Size
2.1.1 Global Pneumococcal Vaccine Revenue 2014-2025
2.1.2 Global Pneumococcal Vaccine Sales 2014-2025
2.2 Pneumococcal Vaccine Growth Rate by Regions
2.2.1 Global Pneumococcal Vaccine Sales by Regions
2.2.2 Global Pneumococcal Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pneumococcal Vaccine Sales by Manufacturers
3.1.1 Pneumococcal Vaccine Sales by Manufacturers
3.1.2 Pneumococcal Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pneumococcal Vaccine Revenue by Manufacturers
3.2.1 Pneumococcal Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Pneumococcal Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Pneumococcal Vaccine Price by Manufacturers
3.4 Pneumococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pneumococcal Vaccine Sales by Product
4.2 Global Pneumococcal Vaccine Revenue by Product
4.3 Pneumococcal Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pneumococcal Vaccine Breakdown Data by End User
6 North America
6.1 North America Pneumococcal Vaccine by Countries
6.1.1 North America Pneumococcal Vaccine Sales by Countries
6.1.2 North America Pneumococcal Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumococcal Vaccine by Product
6.3 North America Pneumococcal Vaccine by End User
7 Europe
7.1 Europe Pneumococcal Vaccine by Countries
7.1.1 Europe Pneumococcal Vaccine Sales by Countries
7.1.2 Europe Pneumococcal Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Vaccine by Product
7.3 Europe Pneumococcal Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccine by Countries
8.1.1 Asia Pacific Pneumococcal Vaccine Sales by Countries
8.1.2 Asia Pacific Pneumococcal Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumococcal Vaccine by Product
8.3 Asia Pacific Pneumococcal Vaccine by End User
9 Central & South America
9.1 Central & South America Pneumococcal Vaccine by Countries
9.1.1 Central & South America Pneumococcal Vaccine Sales by Countries
9.1.2 Central & South America Pneumococcal Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumococcal Vaccine by Product
9.3 Central & South America Pneumococcal Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccine by Countries
10.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries
10.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumococcal Vaccine by Product
10.3 Middle East and Africa Pneumococcal Vaccine by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Pneumococcal Vaccine Products Offered
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GSK Pneumococcal Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 MSD
11.3.1 MSD Company Details
11.3.2 Company Business Overview
11.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 MSD Pneumococcal Vaccine Products Offered
11.3.5 MSD Recent Development
11.4 Sanofipasteur
11.4.1 Sanofipasteur Company Details
11.4.2 Company Business Overview
11.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
11.4.5 Sanofipasteur Recent Development
11.5 CDIBP
11.5.1 CDIBP Company Details
11.5.2 Company Business Overview
11.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 CDIBP Pneumococcal Vaccine Products Offered
11.5.5 CDIBP Recent Development
12 Future Forecast
12.1 Pneumococcal Vaccine Market Forecast by Regions
12.1.1 Global Pneumococcal Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Pneumococcal Vaccine Revenue Forecast by Regions 2019-2025
12.2 Pneumococcal Vaccine Market Forecast by Product
12.2.1 Global Pneumococcal Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Pneumococcal Vaccine Revenue Forecast by Product 2019-2025
12.3 Pneumococcal Vaccine Market Forecast by End User
12.4 North America Pneumococcal Vaccine Forecast
12.5 Europe Pneumococcal Vaccine Forecast
12.6 Asia Pacific Pneumococcal Vaccine Forecast
12.7 Central & South America Pneumococcal Vaccine Forecast
12.8 Middle East and Africa Pneumococcal Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Pneumococcal Vaccine Product Picture
Table Pneumococcal Vaccine Market Segments
Table Key Manufacturers Pneumococcal Vaccine Covered
Table Global Pneumococcal Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Pneumococcal Vaccine Sales Market Share by Product 2014-2025
Figure PPSV 23 Product Picture
Table Major Manufacturers of PPSV 23
Figure PCV 7/13 Product Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Product Picture
Table Major Manufacturers of PCV 10
Table Global Pneumococcal Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Child
Figure Adult
Figure Pneumococcal Vaccine Report Years Considered
Figure Global Pneumococcal Vaccine Market Size 2014-2025 (Million US$)
Figure Global Pneumococcal Vaccine Sales 2014-2025 (K Doses)
Table Global Pneumococcal Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Pneumococcal Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Pneumococcal Vaccine Sales Market Share by Regions 2014-2019
Figure Global Pneumococcal Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Vaccine Sales Market Share by Regions
Table Global Pneumococcal Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Pneumococcal Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Vaccine Revenue Market Share by Regions
Table Global Pneumococcal Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Pneumococcal Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pneumococcal Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Pneumococcal Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Pneumococcal Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Pneumococcal Vaccine Price (2014-2019) (USD/Dose)
Table Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pneumococcal Vaccine Product Type
Table Date of International Manufacturers Enter into Pneumococcal Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by Product (2014-2019)
Figure Global Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure Global Pneumococcal Vaccine Sales Market Share by Product in 2018
Table Global Pneumococcal Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Pneumococcal Vaccine Revenue Share by Product (2014-2019)
Figure Global Pneumococcal Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Pneumococcal Vaccine Revenue Market Share by Product in 2018
Table Pneumococcal Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Pneumococcal Vaccine Market Share by End User (2014-2019)
Figure Global Sales Pneumococcal Vaccine Market Share by End User in 2018
Figure North America Pneumococcal Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Pneumococcal Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pneumococcal Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Vaccine Sales Market Share by Countries
Table North America Pneumococcal Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Vaccine Revenue Market Share by Countries
Figure United States Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Pneumococcal Vaccine Market Share by Product
Table North America Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Pneumococcal Vaccine Market Share by End User
Figure Europe Pneumococcal Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Pneumococcal Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pneumococcal Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Vaccine Sales Market Share by Countries
Table Europe Pneumococcal Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Vaccine Revenue Market Share by Countries
Figure Germany Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pneumococcal Vaccine Market Share by Product
Table Europe Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pneumococcal Vaccine Market Share by End User
Figure Asia Pacific Pneumococcal Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Pneumococcal Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pneumococcal Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccine Sales Market Share by Countries
Table Asia Pacific Pneumococcal Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccine Revenue Market Share by Countries
Figure China Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccine Market Share by Product
Table Asia Pacific Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccine Market Share by End User
Figure Central & South America Pneumococcal Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Pneumococcal Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pneumococcal Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccine Sales Market Share by Countries
Table Central & South America Pneumococcal Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccine Revenue Market Share by Countries
Figure Brazil Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccine Market Share by Product
Table Central & South America Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccine Market Share by End User
Figure Middle East and Africa Pneumococcal Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries
Table Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries
Figure GCC Countries Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pneumococcal Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Pneumococcal Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccine Market Share by Product
Table Middle East and Africa Pneumococcal Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccine Market Share by End User
Table Pfizer Company Details
Table Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table GSK Company Details
Table GSK Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recent Development
Table MSD Company Details
Table MSD Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table MSD Recent Development
Table Sanofipasteur Company Details
Table Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofipasteur Recent Development
Table CDIBP Company Details
Table CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CDIBP Recent Development
Table Global Pneumococcal Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Pneumococcal Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pneumococcal Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Pneumococcal Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pneumococcal Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Pneumococcal Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Pneumococcal Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Pneumococcal Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pneumococcal Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Pneumococcal Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pneumococcal Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Pneumococcal Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pneumococcal Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Pneumococcal Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pneumococcal Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pneumococcal Vaccine Value Chain
Table Pneumococcal Vaccine Customers List
Table Pneumococcal Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Fluconazole Market Research Report 2015-2025
    Published: 05-Apr-2020        Price: US 1800 Onwards        Pages: 79
    Summary The global Fluconazole market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Human Rabies Immunoglobulin (IM) Market Research Report 2015-2025
    Published: 04-Apr-2020        Price: US 1800 Onwards        Pages: 83
    Summary Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. The global Human Rabies Immunoglobulin (IM) market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, ......
  • Global Prostacyclin Market Research Report 2015-2025
    Published: 03-Apr-2020        Price: US 1800 Onwards        Pages: 87
    Summary Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator. The global Prostacyclin market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing mar......
  • Global Protein Drugs Market Size, Status and Forecast 2020-2026
    Published: 03-Apr-2020        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Protein Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Protein Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Eli Lilly - Abbott Laboratories - UCB Group - Schering-Plough Corporation - Genentech - Johnson&Johnson - Bristol-Myer......
  • Global Mebendazole Market Research Report 2020
    Published: 03-Apr-2020        Price: US 2900 Onwards        Pages: 92
    The global Mebendazole market is valued at US$ xx million in 2019 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. This report focuses on Mebendazole volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Mebendazole market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Ch......
  • Histone Deacetylase (HDAC) Inhibitors Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 03-Apr-2020        Price: US 3000 Onwards        Pages: 142
    Histone Deacetylase(HDAC) Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Histone Deacetylase(HDAC) Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Histone Deacetylase(HDAC) Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-d......
  • Subcutaneous Immunoglobulins Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 03-Apr-2020        Price: US 3000 Onwards        Pages: 145
    Subcutaneous Immunoglobulins Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Subcutaneous Immunoglobulins industry with a focus on the Chinese market. The report provides key statistics on the market status of the Subcutaneous Immunoglobulins manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-202......
  • Global Cystic Fibrosis Drugs Market Status and Future Forecast 2015-2025
    Published: 02-Apr-2020        Price: US 4500 Onwards        Pages: 166
    Summary The report forecast global Cystic Fibrosis Drugs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Cystic Fibrosis Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cystic Fibrosis Drugs by geography. The report splits the market size, by volume......
  • Global Corticosteroids Market Status and Future Forecast 2015-2025
    Published: 02-Apr-2020        Price: US 4500 Onwards        Pages: 116
    Summary The report forecast global Corticosteroids market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Corticosteroids industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Corticosteroids by geography. The report splits the market size, by volume and value, on the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs